Aerocrine acquires all business generic drugs.

Aerocrine acquires all business, intellectual property possessions of Apieron Aerocrine AB today announced that it offers acquired all business property and intellectual property property from the bankruptcy estate of Apieron Inc generic drugs . As a total result, Apieron’s litigation against Aerocrine in the U.S. And Germany shall be terminated and dismissed. Aerocrine’s patent infringement claims in the U.S. Against Apieron’s estate will not be dismissed, however. Following Apieron’s launch in the U.S. Germany and S. On March 30th 2010, referring to legal setbacks and insufficient financing, Apieron filed for Chapter 7 bankruptcy. The personal bankruptcy court appointed a trustee to manage the liquidation of Apieron’s assets. Within an auction held on, may 12th in the usa Bankruptcy Court for the Northern District of California, Aerocrine obtained the rights to all of Apieron’s business resources, including its portfolio of patents and trademarks.